[Insulin secretion and hydrocarbon tolerance in essential obesity in women (influence of fenfluramine, phenformin and D-amphetamine)].
D000284:Administration, Oral; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D003913:Dextroamphetamine / Q000008:administration & dosage* / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage* / Q000627:therapeutic use; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D009765:Obesity / Q000188:drug therapy / Q000378:metabolism*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010629:Phenformin / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D005277:Fenfluramine; D010629:Phenformin; D003913:Dextroamphetamine
Secreción de insulina y tolerancia hidrocarbonada en la obesidad esencial de la mujer (influencia de la fenformina, fenfluramina y D-anfetamina.